In 2005, the results of four clinical trials showed that Herceptin is effective in the treatment of early-stage breast cancer that overexpresses HER–2. In all four studies, women who received Herceptin and chemotherapy lived longer and had significantly less chance of the breast cancer coming back than patients who received chemotherapy alone. I can only hope!
They say the most common side effects associated with Herceptin are fever, nausea, vomiting, infusion reactions, diarrhea, infections, increased cough, headache, fatigue, shortness of breath, rash, low white and red blood cells, and muscle pain. I am hoping that once I am only receiving the Herceptin infusions, the side effects will actually lessen.